Depletion of erythrocyte phosphoribosylpyrophosphate in man.
D000284:Administration, Oral; D000328:Adult; D000493:Allopurinol / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D011756:Diphosphates / Q000097:blood* / Q000378:metabolism; D004912:Erythrocytes / Q000032:analysis / Q000378:metabolism*; D005260:Female; D006073:Gout / Q000188:drug therapy; D006461:Hemolysis; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D009711:Nucleotides / Q000378:metabolism; D011687:Purines / Q000096:biosynthesis / Q000652:urine; D011720:Pyrazoles / Q000009:adverse effects / Q000494:pharmacology; D011743:Pyrimidines / Q000009:adverse effects / Q000494:pharmacology; D012266:Ribose / Q000097:blood* / Q000378:metabolism; D014527:Uric Acid / Q000097:blood / Q000652:urine; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
D011756:Diphosphates; D009711:Nucleotides; D011687:Purines; D011720:Pyrazoles; D011743:Pyrimidines; D014527:Uric Acid; D000493:Allopurinol; D012266:Ribose; D014969:Xanthine Oxidase